Structures by: Baradarani M. M.
Total: 8
2-(Diformylmethylidene)-3,3-dimethyl-2,3-dihydro-1H-indole
C13H13NO2
Acta Crystallographica Section E (2006) 62, 2 o737-o738
a=12.1488(13)Å b=12.2273(13)Å c=7.3404(8)Å
α=90.00° β=99.329(2)° γ=90.00°
C17H19N3
C17H19N3
Acta Crystallographica Section C (1995) 51, 7 1345-1347
a=25.166(1)Å b=8.588(1)Å c=18.382(1)Å
α=90° β=136.53(4)° γ=90°
Trans-6,7,8,9,10,11-Hexahydrocycloocta[b]quinoxaline-8,9-diyl diacetate
C18H20N2O4
Acta Crystallographica Section E (2007) 63, 7 o3182-o3182
a=9.4108(8)Å b=12.6470(11)Å c=14.5249(13)Å
α=90.00° β=108.177(2)° γ=90.00°
3-(1-Methylpyrrolidin-2-ylidene)-3<i>H</i>-indole sesquihydrate
C13H14N2,1.5(H2O)
Acta Crystallographica Section E (2009) 65, 12 o3114
a=7.139(5)Å b=10.805(8)Å c=15.737(11)Å
α=88.460(13)° β=88.163(14)° γ=71.506(13)°
1-[(<i>E</i>)-4-(5-Bromo-1<i>H</i>-indol-3-yl)-1-methyl-2,5,6,7-tetrahydro- 1<i>H</i>-azepin-2-ylidene]propan-2-one
C18H19BrN2O
Acta Crystallographica Section E (2010) 66, 7 o1532
a=14.496(2)Å b=6.6677(10)Å c=16.372(3)Å
α=90.00° β=90.267(2)° γ=90.00°
7-Chloro-2-[1-(4-methoxyphenyl)pyrazol-4-yl]-3,3-dimethyl-3<i>H</i>-indole
C20H18ClN3O
Acta Crystallographica Section E (2010) 66, 1 o112
a=11.635(3)Å b=10.328(3)Å c=14.141(4)Å
α=90.00° β=95.681(5)° γ=90.00°
2-[(<i>Z</i>)-4,7-Dichloro-3,3-dimethyl-2,3-dihydro-1<i>H</i>-indol-2- ylidene]-3-oxopropanenitrile
C13H10Cl2N2O
Acta Crystallographica Section E (2012) 68, 1 o233
a=7.0535(8)Å b=7.9455(10)Å c=12.2883(15)Å
α=105.151(2)° β=104.855(2)° γ=95.296(2)°
C14H14ClN3O
C14H14ClN3O
Acta Crystallographica Section E (2012) 68, 1 o234
a=8.226(2)Å b=9.282(3)Å c=9.744(3)Å
α=92.124(5)° β=104.766(5)° γ=105.294(4)°